Development of plant-derived neuroprotective therapeutics to mitigate neuroinflammation and slow Parkinsons disease progression.
Advanced nano-drug delivery systems designed to cross the blood-brain barrier for Alzheimers prevention and management.
Cancer Biology & Oncology
Discovery and advancement of targeted small-molecule drug candidates for colorectal cancer treatment.
Non-invasive, localised drug delivery to enhance local efficacy and minimise systemic toxicity in breast cancer therapy.
Development of multi-target herbal therapeutics to slow or prevent irreversible lung tissue fibrosis.
Translational Glycobiology
Development of novel glyco-immune checkpoint therapies to re-sensitise immunologically "cold" tumours to standard checkpoint inhibitors.
Design and engineer high-affinity nucleic acid aptamers that selectively bind MUC1 tumour-associated glycan antigens (TACAs) for targeted cancer therapy and diagnostic applications.
Regenerative Medicine & Cell-Based Therapeutics
Development of off-the-shelf, cell-free therapeutic biologics for skin regeneration & chronic non-healing wounds that eliminate live-cell transplantation risks.
Design and validate specialised, serum-free media formulations to optimise yield, viability, and stem-like phenotype retention during ex vivo primary T-cell expansion.
